These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 25963924)
1. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database. Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924 [TBL] [Abstract][Full Text] [Related]
2. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer. Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429 [TBL] [Abstract][Full Text] [Related]
3. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study. Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508 [TBL] [Abstract][Full Text] [Related]
4. Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database. Castillo JJ; Olszewski AJ; Hunter ZR; Kanan S; Meid K; Treon SP Cancer; 2015 Jul; 121(13):2230-6. PubMed ID: 25757851 [TBL] [Abstract][Full Text] [Related]
5. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935 [TBL] [Abstract][Full Text] [Related]
6. Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database. Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP Br J Haematol; 2015 Apr; 169(1):81-9. PubMed ID: 25521528 [TBL] [Abstract][Full Text] [Related]
7. Stage at diagnosis and early mortality from cancer in England. McPhail S; Johnson S; Greenberg D; Peake M; Rous B Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389 [TBL] [Abstract][Full Text] [Related]
8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related]
9. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. Kato I; Booza J; Quarshie WO; Schwartz K J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021 [TBL] [Abstract][Full Text] [Related]
10. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761 [TBL] [Abstract][Full Text] [Related]
11. [Reference data on survival of cancer patients in 17 European countries]. Sant M Epidemiol Prev; 2000; 24(1):44-5. PubMed ID: 10748550 [No Abstract] [Full Text] [Related]
12. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients. Milano MT; Li H; Constine LS; Travis LB Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074 [TBL] [Abstract][Full Text] [Related]
13. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Hjalgrim H; Frisch M; Storm HH; Glimelius B; Pedersen JB; Melbye M Int J Cancer; 2000 Mar; 85(5):639-42. PubMed ID: 10699942 [TBL] [Abstract][Full Text] [Related]
14. Second primary cancers in the Vaud and Neuchâtel Cancer Registries. Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586 [TBL] [Abstract][Full Text] [Related]
15. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma. Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study. Holmes S; Griffith EJ; Musto G; Minuk GY Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077 [TBL] [Abstract][Full Text] [Related]
18. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054 [TBL] [Abstract][Full Text] [Related]
19. Cancer mortality surveillance--United States, 1990-2000. Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359 [TBL] [Abstract][Full Text] [Related]
20. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers. Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]